Coronary stenting

PROCEDURE7 trials

Sponsors

University of Rome Tor Vergata, OrbusNeich, Boston Scientific Corporation, Johannes Gutenberg University Mainz, Svelte Medical Systems, Inc.

Conditions

Acute-Phase ReactionAtherosclerosisCoronary ArteriosclerosesCoronary Artery DiseaseCoronary Artery LesionsCoronary Heart DiseaseMyocardial Ischemia

Phase 2

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

CompletedNCT00967902

OrbusNeichCoronary Artery Lesions

Start: 2009-11-30End: 2015-09-30Updated: 2016-03-29

Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease

CompletedNCT02701140

Italo PortoMyocardial Ischemia

Start: 2016-06-30End: 2020-11-30Updated: 2020-11-16

Phase 4

Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

University of Rome Tor VergataAcute-Phase Reaction, Atherosclerosis

Start: 2007-07-31End: 2009-01-31Target: 100Updated: 2007-06-12

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

CompletedNCT01700322

Johannes Gutenberg University MainzCoronary Artery Disease

Start: 2012-08-31End: 2016-09-30Updated: 2016-09-07

Unknown Phase

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study

CompletedNCT01148329

Boston Scientific CorporationCoronary Heart Disease

Start: 2010-06-30End: 2016-12-31Updated: 2017-02-02

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

CompletedNCT01788150

Svelte Medical Systems, Inc.Coronary Artery Disease

Start: 2013-01-31End: 2019-05-31Updated: 2021-05-04

TransRadial Ultra Support Technique (TRUST)

CompletedNCT03025685

Meshalkin Research Institute of Pathology of CirculationCoronary Arterioscleroses, Coronary Artery Disease

Start: 2016-09-30End: 2016-12-31Updated: 2017-12-27

Related Papers

Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study

European Heart Journal - Cardiovascular Pharmacotherapy2023-11-247 citations

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial

Frontiers in Cardiovascular Medicine2021-12-133 citations

Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial.

2020-02-179 citations

Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study

BMJ Open2014-05-0125 citations